DK3405197T3 - Topisk behandling af håndeksem - Google Patents

Topisk behandling af håndeksem Download PDF

Info

Publication number
DK3405197T3
DK3405197T3 DK17701828.0T DK17701828T DK3405197T3 DK 3405197 T3 DK3405197 T3 DK 3405197T3 DK 17701828 T DK17701828 T DK 17701828T DK 3405197 T3 DK3405197 T3 DK 3405197T3
Authority
DK
Denmark
Prior art keywords
topical treatment
hand eczema
eczema
hand
topical
Prior art date
Application number
DK17701828.0T
Other languages
English (en)
Inventor
Tero Wennberg
Anders Per Sørensen
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Application granted granted Critical
Publication of DK3405197T3 publication Critical patent/DK3405197T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
DK17701828.0T 2016-01-21 2017-01-20 Topisk behandling af håndeksem DK3405197T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16152215 2016-01-21
PCT/EP2017/051133 WO2017125523A1 (en) 2016-01-21 2017-01-20 Treatment of hand eczema

Publications (1)

Publication Number Publication Date
DK3405197T3 true DK3405197T3 (da) 2023-11-27

Family

ID=55236207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17701828.0T DK3405197T3 (da) 2016-01-21 2017-01-20 Topisk behandling af håndeksem

Country Status (25)

Country Link
US (2) US20200397787A1 (da)
EP (2) EP3405197B1 (da)
JP (1) JP6929860B2 (da)
KR (1) KR20180102662A (da)
CN (3) CN108472297A (da)
AU (2) AU2017209932A1 (da)
BR (1) BR112018014769A2 (da)
CA (1) CA3010547A1 (da)
DK (1) DK3405197T3 (da)
ES (1) ES2963784T3 (da)
FI (1) FI3405197T3 (da)
HR (1) HRP20231448T1 (da)
HU (1) HUE064192T2 (da)
IL (2) IL297379A (da)
LT (1) LT3405197T (da)
MX (2) MX2018008449A (da)
PL (1) PL3405197T3 (da)
PT (1) PT3405197T (da)
RS (1) RS64798B1 (da)
RU (1) RU2018130097A (da)
SG (2) SG10202006830WA (da)
SI (1) SI3405197T1 (da)
TW (1) TWI783921B (da)
UA (1) UA123780C2 (da)
WO (1) WO2017125523A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021022031A2 (pt) * 2019-05-15 2021-12-28 Leo Pharma As Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica
MX2023008904A (es) * 2021-02-02 2023-08-09 Pfizer Inc Regimen de dosificacion para el tratamiento del eczema cronico de manos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
WO2012071654A1 (en) * 2010-11-30 2012-06-07 Bio-K Plus International Inc. Treatment and prevention of eczema
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent

Also Published As

Publication number Publication date
CN108472297A (zh) 2018-08-31
CA3010547A1 (en) 2017-07-27
TW201736382A (zh) 2017-10-16
RS64798B1 (sr) 2023-11-30
IL260094A (en) 2018-07-31
CN117159553A (zh) 2023-12-05
IL297379A (en) 2022-12-01
HUE064192T2 (hu) 2024-02-28
EP4257205A2 (en) 2023-10-11
RU2018130097A3 (da) 2020-05-25
SG10202006830WA (en) 2020-08-28
SG11201805394QA (en) 2018-08-30
US20230138114A1 (en) 2023-05-04
PT3405197T (pt) 2023-12-06
US20200397787A1 (en) 2020-12-24
LT3405197T (lt) 2023-11-27
MX2022005915A (es) 2022-06-27
PL3405197T3 (pl) 2024-02-12
HRP20231448T1 (hr) 2024-03-01
KR20180102662A (ko) 2018-09-17
FI3405197T3 (fi) 2023-11-23
AU2017209932A1 (en) 2018-07-05
TW202332451A (zh) 2023-08-16
UA123780C2 (uk) 2021-06-02
TWI783921B (zh) 2022-11-21
EP4257205A3 (en) 2023-12-20
AU2022252766A1 (en) 2022-11-03
SI3405197T1 (sl) 2024-03-29
JP6929860B2 (ja) 2021-09-01
EP3405197B1 (en) 2023-09-06
ES2963784T3 (es) 2024-04-02
EP3405197A1 (en) 2018-11-28
CN117159554A (zh) 2023-12-05
MX2018008449A (es) 2018-08-09
JP2019502734A (ja) 2019-01-31
RU2018130097A (ru) 2020-02-21
BR112018014769A2 (pt) 2018-12-11
WO2017125523A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3134530T3 (da) Behandling af hyperbilirubinæmi
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3120831T3 (da) Topikal levering af hudsammensætninger med lav ph
DK3302565T3 (da) Faste doseringsformer af palbociclib
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3554240T3 (da) Kombinationer af aktive forbindelser
DK2968208T3 (da) Behandling af kataplexi
DK3458052T3 (da) Kombinationsbehandling af cancer
DK3325662T3 (da) Epigenetisk inaktivering af nmt2
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
DK3261726T3 (da) Sammensætning til behandling af acne
DK3307267T3 (da) Behandling af multipel sklerose
DK3506904T3 (da) Behandling af demens
DK3512857T3 (da) Spiro-bicykliske inhibitorer af menin-mll-interaktion
DK3318115T3 (da) Maskine til behandling af svinegylle
DK3283210T3 (da) Fremgangsmåde
DK3060226T3 (da) Fagterapi af pseudomonasinfektioner
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3532076T3 (da) Immunterapeutiske behandlinger af tumorer
DK3073409T3 (da) Maskering af forskellige indholdstyper
DK3418273T3 (da) Derivater af flavagliner
DK3430004T3 (da) Faststofformer af nilotinibsalte